ENDRA Life Sciences (NDRA) Receivables - Other (2024)

ENDRA Life Sciences (NDRA) posted quarterly Receivables - Other of $799284.0 for Q4 2024, down 12.22% quarter-over-quarter from $910556.0 in Q3 2024.

ENDRA Life Sciences (NDRA) Receivables - Other (2024) Analysis & Trends

ENDRA Life Sciences (NDRA) has reported Receivables - Other for 1 consecutive years, with $799284.0 the latest figure, recorded in Q4 2024.

In Q4 2024, Receivables - Other changed N/A year-over-year to $799284.0; the TTM figure through Dec 2024 stood at $799284.0 (changed N/A YoY), while the FY2024 annual figure was $799284.0, changed N/A from the prior year.
Receivables - Other fell to $799284.0 in Q4 2024 per NDRA's latest filing, from $910556.0 in the prior quarter.
Across five years, Receivables - Other topped out at $910556.0 in Q3 2024 and bottomed at $799284.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn
10	ENDRA Life Sciences	5.44 Mn	5.08 Mn	-

Download Data